Related Experiment Videos
In vitro interaction between Saccharomyces cerevisiae CDC25 and RAS2 proteins
M D Baroni1, G Marconi, M C Parrini
1Dipartimento di Fisiologia e Biochimica Generali, Università degli Studi di Milano, Italy.
Biochemical and Biophysical Research Communications
|July 15, 1992
Summary
Researchers investigated the interaction between CDC25 and RAS2 proteins in yeast. They found specific binding occurs between the C-terminal regions of both proteins, crucial for the RAS/cAMP pathway.
Area of Science:
- Molecular Biology
- Yeast Genetics
- Cell Signaling
Background:
- The CDC25 protein in Saccharomyces cerevisiae positively regulates the RAS/cAMP pathway.
- CDC25 enhances the GDP-releasing rate of the RAS2 protein, a key component of this pathway.
Purpose of the Study:
- To determine if a direct physical interaction occurs between the CDC25 and RAS2 proteins.
- To identify the specific domains of CDC25 and RAS2 involved in their interaction.
Main Methods:
- Co-immunoprecipitation assays were used to detect protein-protein interactions.
- Truncated versions of RAS2 and CDC25 proteins were employed to map interaction domains.
Main Results:
- The whole RAS2 protein and a truncated version lacking 25 C-terminal residues specifically interact with CDC25.
- A RAS2 derivative lacking 112 C-terminal residues did not bind CDC25.
- The C-terminal 310 amino acids of CDC25 bind RAS2, and deletion within this region abolishes binding.
Conclusions:
- A direct interaction between CDC25 and RAS2 proteins was demonstrated.
- Specific C-terminal regions of both RAS2 and CDC25 are essential for their binding.
- These findings provide insight into the molecular mechanisms regulating the RAS/cAMP pathway in yeast.